Phenyl-oxazoles, a new family of inverse agonists at the H(3) histamine receptor. 2010

Frédéric Denonne, and Franck Atienzar, and Sylvain Célanire, and Bernard Christophe, and Frédérique Delannois, and Christel Delaunoy, and Marie-Laure Delporte, and Véronique Durieu, and Michel Gillard, and Bénédicte Lallemand, and Yves Lamberty, and Geneviève Lorent, and Alain Vanbellinghen, and Nathalie Van Houtvin, and Valérie Verbois, and Laurent Provins
UCB New Medicines, Chemin du Foriest, 1420 Braine-L'Alleud, Belgium. Frederic.denonne@ucb.com

UI MeSH Term Description Entries
D008297 Male Males
D008862 Microsomes, Liver Closed vesicles of fragmented endoplasmic reticulum created when liver cells or tissue are disrupted by homogenization. They may be smooth or rough. Liver Microsomes,Liver Microsome,Microsome, Liver
D010080 Oxazoles Five-membered heterocyclic ring structures containing an oxygen in the 1-position and a nitrogen in the 3-position, in distinction from ISOXAZOLES where they are at the 1,2 positions. Oxazole,1,3-Oxazolium-5-Oxides,Munchnones,1,3 Oxazolium 5 Oxides
D011759 Pyrrolidines Compounds also known as tetrahydropyridines with general molecular formula (CH2)4NH. Tetrahydropyridine,Tetrahydropyridines
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D003072 Cognition Disorders Disorders characterized by disturbances in mental processes related to learning, thinking, reasoning, and judgment. Overinclusion,Disorder, Cognition,Disorders, Cognition
D006633 Histamine Antagonists Drugs that bind to but do not activate histamine receptors, thereby blocking the actions of histamine or histamine agonists. Classical antihistaminics block the histamine H1 receptors only. Antihistamine,Antihistamines,Histamine Antagonist,Antagonist, Histamine,Antagonists, Histamine
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001554 Benzene Toxic, volatile, flammable liquid hydrocarbon byproduct of coal distillation. It is used as an industrial solvent in paints, varnishes, lacquer thinners, gasoline, etc. Benzene causes central nervous system damage acutely and bone marrow damage chronically and is carcinogenic. It was formerly used as parasiticide. Benzol,Benzole,Cyclohexatriene

Related Publications

Frédéric Denonne, and Franck Atienzar, and Sylvain Célanire, and Bernard Christophe, and Frédérique Delannois, and Christel Delaunoy, and Marie-Laure Delporte, and Véronique Durieu, and Michel Gillard, and Bénédicte Lallemand, and Yves Lamberty, and Geneviève Lorent, and Alain Vanbellinghen, and Nathalie Van Houtvin, and Valérie Verbois, and Laurent Provins
July 2009, ChemMedChem,
Frédéric Denonne, and Franck Atienzar, and Sylvain Célanire, and Bernard Christophe, and Frédérique Delannois, and Christel Delaunoy, and Marie-Laure Delporte, and Véronique Durieu, and Michel Gillard, and Bénédicte Lallemand, and Yves Lamberty, and Geneviève Lorent, and Alain Vanbellinghen, and Nathalie Van Houtvin, and Valérie Verbois, and Laurent Provins
January 2014, Expert opinion on therapeutic patents,
Frédéric Denonne, and Franck Atienzar, and Sylvain Célanire, and Bernard Christophe, and Frédérique Delannois, and Christel Delaunoy, and Marie-Laure Delporte, and Véronique Durieu, and Michel Gillard, and Bénédicte Lallemand, and Yves Lamberty, and Geneviève Lorent, and Alain Vanbellinghen, and Nathalie Van Houtvin, and Valérie Verbois, and Laurent Provins
January 2012, Bioorganic & medicinal chemistry letters,
Frédéric Denonne, and Franck Atienzar, and Sylvain Célanire, and Bernard Christophe, and Frédérique Delannois, and Christel Delaunoy, and Marie-Laure Delporte, and Véronique Durieu, and Michel Gillard, and Bénédicte Lallemand, and Yves Lamberty, and Geneviève Lorent, and Alain Vanbellinghen, and Nathalie Van Houtvin, and Valérie Verbois, and Laurent Provins
January 2011, Current pharmaceutical design,
Frédéric Denonne, and Franck Atienzar, and Sylvain Célanire, and Bernard Christophe, and Frédérique Delannois, and Christel Delaunoy, and Marie-Laure Delporte, and Véronique Durieu, and Michel Gillard, and Bénédicte Lallemand, and Yves Lamberty, and Geneviève Lorent, and Alain Vanbellinghen, and Nathalie Van Houtvin, and Valérie Verbois, and Laurent Provins
January 2011, Current topics in medicinal chemistry,
Frédéric Denonne, and Franck Atienzar, and Sylvain Célanire, and Bernard Christophe, and Frédérique Delannois, and Christel Delaunoy, and Marie-Laure Delporte, and Véronique Durieu, and Michel Gillard, and Bénédicte Lallemand, and Yves Lamberty, and Geneviève Lorent, and Alain Vanbellinghen, and Nathalie Van Houtvin, and Valérie Verbois, and Laurent Provins
August 2009, Bioorganic & medicinal chemistry letters,
Frédéric Denonne, and Franck Atienzar, and Sylvain Célanire, and Bernard Christophe, and Frédérique Delannois, and Christel Delaunoy, and Marie-Laure Delporte, and Véronique Durieu, and Michel Gillard, and Bénédicte Lallemand, and Yves Lamberty, and Geneviève Lorent, and Alain Vanbellinghen, and Nathalie Van Houtvin, and Valérie Verbois, and Laurent Provins
February 2012, Bioorganic & medicinal chemistry letters,
Frédéric Denonne, and Franck Atienzar, and Sylvain Célanire, and Bernard Christophe, and Frédérique Delannois, and Christel Delaunoy, and Marie-Laure Delporte, and Véronique Durieu, and Michel Gillard, and Bénédicte Lallemand, and Yves Lamberty, and Geneviève Lorent, and Alain Vanbellinghen, and Nathalie Van Houtvin, and Valérie Verbois, and Laurent Provins
April 2006, Inflammation research : official journal of the European Histamine Research Society ... [et al.],
Frédéric Denonne, and Franck Atienzar, and Sylvain Célanire, and Bernard Christophe, and Frédérique Delannois, and Christel Delaunoy, and Marie-Laure Delporte, and Véronique Durieu, and Michel Gillard, and Bénédicte Lallemand, and Yves Lamberty, and Geneviève Lorent, and Alain Vanbellinghen, and Nathalie Van Houtvin, and Valérie Verbois, and Laurent Provins
January 2012, Bioorganic & medicinal chemistry letters,
Frédéric Denonne, and Franck Atienzar, and Sylvain Célanire, and Bernard Christophe, and Frédérique Delannois, and Christel Delaunoy, and Marie-Laure Delporte, and Véronique Durieu, and Michel Gillard, and Bénédicte Lallemand, and Yves Lamberty, and Geneviève Lorent, and Alain Vanbellinghen, and Nathalie Van Houtvin, and Valérie Verbois, and Laurent Provins
September 2011, Bioorganic & medicinal chemistry letters,
Copied contents to your clipboard!